Antiphospholipid syndrome (APS) is the association of thrombosis and/or pregnancy
morbidity with antiphospholipid antibodies (aPL). Thirty to forty percent of systemic lupus …

Cognitive dysfunction (CD) is a common yet often clinically subtle manifestation that
considerably impacts the health-related quality of life in patients with systemic lupus …

Abstract Purpose of Review In recent years, the spectrum of neurological manifestations of
antiphospholipid syndrome (APS) has been growing. We provide a critical review of the …

Objectives To systematically review the literature on the prevalence of Cognitive Dysfunction
(CD) in SLE patients in studies that used a specified neuropsychological instrument …

Objective: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, in which
cognitive dysfunction is common, but poorly understood. This study aims to characterize the …

Cognitive deficits are common in patients with systemic lupus erythematosus (SLE)
regardless of overt neuropsychiatric involvement; however, a clear neuropsychological …

Introduction Antiphospholipid antibodies (aPL) have been associated with organ damage
and certain features in systemic lupus erythematosus (SLE) patients. Our aim was to …

Thrombotic manifestations of antiphospholipid syndrome (APS) are well known, and various
non-stroke neuro-psychiatric manifestations (NPMs) have also been consistently described …

Objectives To compare the magnitude of cognitive impairment against age-expected levels
across the immune mediated inflammatory diseases (IMIDs: systemic lupus erythematosus …

Objective To review: 1) degree of conformity to the American College of Rheumatology
neuropsychological battery (ACR-NB) among studies that used a NB, 2) review definitions of …